The effect of neoadjuvant radiotherapy on immune cell infiltrates in myxofibrosarcoma
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Myxofibrosarcoma (MFS) is a subtype of soft-tissue sarcoma for which local treatment includes neoadjuvant radiotherapy (nRT) followed by surgery. The impact of nRT on the MFS tumor immune microenvironment remains unexplored. Materials and methods: Paired pre-nRT biopsy and post-nRT surgery samples from 31 MFS patients were retrospectively collected. The intratumoral density of T cells, cytotoxic T cells, regulatory T cells, helper T cells, B cells and natural killer (NK) cells and expression of programmed death-ligand 1 were quantified using multiplex immunohistochemistry (mIHC). mIHC marker densities were compared between pre- and post-nRT samples, and their associations with clinicopathological characteristics and patient outcomes were assessed. Results: = 0.050] infiltration, was observed following nRT. There were no statistically significant associations between mIHC marker densities measured before or after nRT, or their changes over time, and patient outcomes. Conclusions: Conventional nRT is associated with reduced cytotoxic and helper T cell infiltration and increased presence of NK cells in MFS. These results suggest that conventional nRT reduces inflammatory aspects of MFS tumors.
Source: Immuno-Oncology Technology
Authors: M.J.L. Nederkoorn, U.E. Flucke, M.H.S. Hillebrandt-Roeffen, M.A.J. Gorris, S.G. van Ravensteijn, K. Verrijp, P.M. Braam, J.J. Bonenkamp, E.F. Dierselhuis, E. Ruijter, C. Wetzels-van der Velden, H.V.N. Kusters-Vandevelde, C.J.R. Huysentruyt, J.M.M. Grefte, J.H.W. de Wilt, I.M.E. Desar, Y.M.H. Versleijen-Jonkers
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,340
OpenAlex ID: W7130846616
